Ein Mann liest Wirtschaftsnachrichten (Symbolbild).
Mittwoch, 20.02.2013 15:06 von | Aufrufe: 265

Mazor Robotics Renaissance™ reaches milestone with spine surgeons placing over 1,000 implants percutaneously

Ein Mann liest Wirtschaftsnachrichten (Symbolbild). pixabay.com

PR Newswire

NORCROSS, Ga., Feb. 20, 2013 /PRNewswire/ -- While only 10 to 15 percent of all spine surgeries are performed using minimally-invasive surgical (MIS) techniques, 25 percent of all Renaissance™ cases (1,019 and rising) have been executed percutaneously.  Mazor Robotics, recently named one of The World's 50 Most Innovative Companies by Fast Company, offers advantages to patients and surgeons alike with Renaissance™, a surgical guidance system for spine and brain surgery.  Mazor Robotics technology is available at over 40 spine centers worldwide and has been used in thousands of spine procedures to date.

Although MIS spine surgery provides patients with benefits such as less scarring and shorter recovery time, surgeons performing such procedures have a higher risk of cancer due to the prolonged radiation exposure (fluoroscopy). In 2012, Faissal Zahrawi, MD, FACS, founder of Celebration (Fla.) Minimally Invasive Spine Institute, presented to The International Society for Minimal Intervention in Spinal Surgery (ISMISS) on the potential for reducing fluoroscopy in MIS spine surgery when using Renaissance™.   Earlier this year, Dr. Zahrawi celebrated his 100th successful MIS case using Renaissance™.

Dr. Sven Kantelhardt's study in the European Spine Journal states "the use of robotic-guidance significantly increased accuracy of screw positioning while reducing the X-ray exposure."1 In comparison to freehand spine surgery, this clinical study proved that using Renaissance™:

  • improved implant accuracy by 70 percent,
  • reduced X-ray dosage by 56 percent,
  • reduced complication rates by 48 percent,
  • reduced need for re-operations by 46 percent, and
  • reduced average length of hospital stay by 27 percent.

Additional peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology.  For more information, please visit www.MazorRobotics.com.

About Mazor
Mazor Robotics (TASE:MZOR) is dedicated to the development of innovative surgical guidance systems and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics' systems have been successfully used in the placement of tens of thousands of implants in the United States and Europe. 

1. Kantelhardt SR, Martinez R, Baerwinkel S, Burger R, Giese A, Rohde V. Perioperative course and accuracy of screw positioning in conventional, open robotic-guided and percutaneous robotic-guided, pedicle screw placement.
Eur Spine J. 2011;20(6):860-868.

Contact: Stephani Newman
Marketing Communications Manager
Mazor Robotics, Inc.
S.Newman@MazorRobotics-US.com
1 (800) 80 – MAZOR


ARIVA.DE Börsen-Geflüster

Kurse

 

SOURCE Mazor Robotics

Werbung

Mehr Nachrichten zur Mazor Robotics ADR Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News